Denmark became the first country in Europe to abandon use of the AstraZeneca COVID-19 vaccine, after the country and more than a dozen other European Union nations suspended its usage.
Denmark's health agency director, Soren Brostrom, said Denmark won't use the shot as part of its vaccination campaign—even as the World Health Organization (WHO) and EU's European Medicines Agency (EMA) have said the benefits of using the AstraZeneca shot outweigh the negatives amid reports of rare blood clots.
"Overall, we must say that the results show that there is a real and serious side effect signal in the vaccine from AstraZeneca," said Brostrom in a statement. "Based on an overall consideration, we have therefore chosen to continue the vaccination programme for all target groups without this vaccine."
Noting that it's been a "difficult decision" to make, Brostrom said the "upcoming target groups for vaccination are less likely to become severely ill from COVID-19," and officials "must weigh this against the fact that we now have a known risk of severe adverse effects from vaccination with AstraZeneca, even if the risk in absolute terms is slight."
The CCP (Chinese Communist Party) virus is also known as the novel coronavirus.
In March, most of the countries that stopped using the AstraZeneca vaccine ultimately resumed its use.
“So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed,” it stated.
The decision to not use AstraZeneca's shot will push back the scheduled conclusion of Denmark’s vaccination scheme to early August from July 25, Danish officials said. Denmark also uses the U.S.-made Pfizer/BioNTech vaccine, which requires two shots.
Denmark was also the first nation to stop using the vaccine in March.
AstraZeneca officials didn't immediately respond to a request by The Epoch Times for comment.
This week, U.S. health agencies recommended that the single-shot Johnson & Johnson vaccine be suspended amid reports of blood clots. Former President Donald Trump, in a statement, criticized the decision, saying that he believes it was halted for "possibly political reasons," as the Food and Drug Administration has more "love for Pfizer."